Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 1.22 million. The enterprise value is -528,725.
| Market Cap | 1.22M |
| Enterprise Value | -528,725 |
Important Dates
The last earnings date was Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.34 million shares outstanding. The number of shares has increased by 69.48% in one year.
| Current Share Class | 11.34M |
| Shares Outstanding | 17.34M |
| Shares Change (YoY) | +69.48% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 34.67% |
| Owned by Institutions (%) | n/a |
| Float | 7.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.42 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.05 |
| Quick Ratio | 2.75 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -87.49 |
Financial Efficiency
Return on equity (ROE) is -45.71% and return on invested capital (ROIC) is -25.05%.
| Return on Equity (ROE) | -45.71% |
| Return on Assets (ROA) | -20.65% |
| Return on Invested Capital (ROIC) | -25.05% |
| Return on Capital Employed (ROCE) | -57.50% |
| Revenue Per Employee | 98,667 |
| Profits Per Employee | -16,660 |
| Employee Count | 94 |
| Asset Turnover | 1.95 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.54% in the last 52 weeks. The beta is 4.62, so Syra Health's price volatility has been higher than the market average.
| Beta (5Y) | 4.62 |
| 52-Week Price Change | -82.54% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 47.58 |
| Average Volume (20 Days) | 19,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Syra Health had revenue of 7.50 million and -1.27 million in losses. Loss per share was -0.11.
| Revenue | 7.50M |
| Gross Profit | 2.23M |
| Operating Income | -1.27M |
| Pretax Income | -1.27M |
| Net Income | -1.27M |
| EBITDA | -1.24M |
| EBIT | -1.27M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 1.98 million in cash and 232,349 in debt, giving a net cash position of 1.74 million or 0.10 per share.
| Cash & Cash Equivalents | 1.98M |
| Total Debt | 232,349 |
| Net Cash | 1.74M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 2.21M |
| Book Value Per Share | 0.13 |
| Working Capital | 2.16M |
Cash Flow
| Operating Cash Flow | -373,274 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 29.76%, with operating and profit margins of -16.94% and -16.89%.
| Gross Margin | 29.76% |
| Operating Margin | -16.94% |
| Pretax Margin | -16.89% |
| Profit Margin | -16.89% |
| EBITDA Margin | -16.60% |
| EBIT Margin | -16.94% |
| FCF Margin | n/a |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -69.48% |
| Shareholder Yield | -69.48% |
| Earnings Yield | -104.17% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |